201 related articles for article (PubMed ID: 15026566)
1. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
Nykamp DL; Fackih MN; Compton AL
Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
[TBL] [Abstract][Full Text] [Related]
2. Consumption of dietary supplements containing Citrus aurantium (bitter orange)--2004 California Behavioral Risk Factor Surveillance Survey (BRFSS).
Klontz KC; Timbo BB; Street D
Ann Pharmacother; 2006 Oct; 40(10):1747-51. PubMed ID: 16968826
[TBL] [Abstract][Full Text] [Related]
3. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
[TBL] [Abstract][Full Text] [Related]
4. Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city.
Sharpe PA; Granner ML; Conway JM; Ainsworth BE; Dobre M
J Am Diet Assoc; 2006 Dec; 106(12):2045-51. PubMed ID: 17126636
[TBL] [Abstract][Full Text] [Related]
5. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement.
Sultan S; Spector J; Mitchell RM
Mayo Clin Proc; 2006 Dec; 81(12):1630-1. PubMed ID: 17165643
[TBL] [Abstract][Full Text] [Related]
6. Ephedra-associated cardiomyopathy.
Naik SD; Freudenberger RS
Ann Pharmacother; 2004 Mar; 38(3):400-3. PubMed ID: 14742827
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
Nelson BC; Putzbach K; Sharpless KE; Sander LC
J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
[TBL] [Abstract][Full Text] [Related]
8. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.
Haaz S; Fontaine KR; Cutter G; Limdi N; Perumean-Chaney S; Allison DB
Obes Rev; 2006 Feb; 7(1):79-88. PubMed ID: 16436104
[TBL] [Abstract][Full Text] [Related]
9. Bitter orange weight loss products may not be safe.
Health News; 2004 Dec; 10(12):9. PubMed ID: 15645567
[No Abstract] [Full Text] [Related]
10. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?
Allison DB; Cutter G; Poehlman ET; Moore DR; Barnes S
Int J Obes (Lond); 2005 Apr; 29(4):443-6. PubMed ID: 15700046
[TBL] [Abstract][Full Text] [Related]
11. Use of nonprescription dietary supplements for weight loss is common among Americans.
Blanck HM; Serdula MK; Gillespie C; Galuska DA; Sharpe PA; Conway JM; Khan LK; Ainsworth BE
J Am Diet Assoc; 2007 Mar; 107(3):441-7. PubMed ID: 17324663
[TBL] [Abstract][Full Text] [Related]
12. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions.
Jordan S; Murty M; Pilon K
CMAJ; 2004 Oct; 171(8):993-4. PubMed ID: 15497209
[No Abstract] [Full Text] [Related]
13. Herbal weight-loss supplement misadventures per a regional poison center.
Robinson RF; Griffith JR; Nahata MC; Mahan JD; Casavant MJ
Ann Pharmacother; 2004 May; 38(5):787-90. PubMed ID: 15044657
[TBL] [Abstract][Full Text] [Related]
14. Response of CEDIA amphetamines assay after a single dose of bitter orange.
Nguyen DT; Bui LT; Ambrose PJ
Ther Drug Monit; 2006 Apr; 28(2):252-4. PubMed ID: 16628139
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure and heart rate effects following a single dose of bitter orange.
Bui LT; Nguyen DT; Ambrose PJ
Ann Pharmacother; 2006 Jan; 40(1):53-7. PubMed ID: 16317106
[TBL] [Abstract][Full Text] [Related]
16. [Risk assessment of synephrine in dietary supplements].
Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
[TBL] [Abstract][Full Text] [Related]
17. Safety of herbal supplements: a guide for cardiologists.
Cohen PA; Ernst E
Cardiovasc Ther; 2010 Aug; 28(4):246-53. PubMed ID: 20633025
[TBL] [Abstract][Full Text] [Related]
18. Physiological effects following administration of Citrus aurantium for 28 days in rats.
Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
[TBL] [Abstract][Full Text] [Related]
19. A case report of atrial fibrillation potentially induced by hydroxycut: a multicomponent dietary weight loss supplement devoid of sympathomimetic amines.
Karth A; Holoshitz N; Kavinsky CJ; Trohman R; McBride BF
J Pharm Pract; 2010 Jun; 23(3):245-9. PubMed ID: 21507821
[TBL] [Abstract][Full Text] [Related]
20. Acute tubular necrosis associated with chromium picolinate-containing dietary supplement.
Wani S; Weskamp C; Marple J; Spry L
Ann Pharmacother; 2006 Mar; 40(3):563-6. PubMed ID: 16492795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
